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Abstract
Patent protection may decrease R&D incentives due to the tournament effect. In
this paper, we show that patent protection in the presence of a cooperative R&D option
always increases the R&D incentive. In addition, this option dominates imitation to
increase the R&D incentive under patent protection, and may also dominate royalty
licensing depending on the R&D cost.
JEL classification : O31; O34; O38.
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1 Introduction
Patent protection has been widely applied as one of the most important mechanisms
for encouraging the R&D incentive and reducing technology free riding (spillover) among
competitive firms. However, Roy Chowdhury (2005) shows that patent protection may
adversely decrease the R&D incentive via the tournament effect (TE) if firms simultaneously
undertake similar activities of technology innovation. In the same scenario, Mukherjee (2006)
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claims that the effect of either imitation or royalty licensing under patent protection is likely
to dominate TE, and create higher R&D investment.
There is also a large body of literature discussing the possibility of cooperative R&D
among firms, such as d’Aspremont and Jacquemin (1988), Kamien, Muller, and Zang (1992),
Suzumura (1992), and the following papers. They show that welfare would be improved if
firms cooperate in the R&D stage and then compete in product market.
In this paper, we incorporate a cooperative R&D option into patent protection for en-
couraging R&D incentives. We show that patent protection always increases R&D incentives
in the presence of a cooperative R&D option. In addition, this option dominates imitation to
increase R&D incentives under patent protection, and may also dominate royalty licensing
depending on the magnitude of the R&D cost.
2 The Setup
Suppose that a duopoly market consists of two firms, i = 1, 2, who produce a homoge-
neous good. Let qi be the output of firm i. The inverse market demand function is f(q),
where q = q1 + q2, and it satisfies that f
′ < 0 and f ′ + qif ′′ < 0,∀q, qi. Initially, each firm
produces with the cost function cq and receives the profit pi(., .), in which the first (second)
argument represents the marginal cost of firm 1 (firm 2). Nevertheless, by investing an
amount F > 0 in R&D, each firm’s cost function changes to c′q, where c′ ∈ [0, c).
Let us consider a two-stage game. In stage 1, both firms simultaneously decide whether
to invest F in R&D or not. Under no patent protection, the firm who does not invest in
R&D benefits from the technology spillover of the rival who invests; the marginal cost of
the non-innovating firm decreases from c to c˜, where c′ ≤ c˜ ≤ c. Under patent protection,
this possibility of technology spillover (free riding) is eliminated; the marginal cost of the
non-innovating firm remains at c. In stage 2, two firms have the Cournot competition in
the product market. Following Roy Chowdhury (2005), the natural rank in stage 2 of the
duopoly profits is given by pi1(c
′, c) = pi2(c, c′) > pi(c′, c′) > pi(c, c) > pi1(c, c′) = pi2(c′, c), and
for c˜ < c, pi1(c
′, c) > pi1(c′, c˜) = pi2(c˜, c′) and pi2(c′, c˜) = pi1(c˜, c′) > pi1(c, c′).
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To ensure that both firms are willing to simultaneously invest in R&D, we assume that
Assumption 1. pi(c′, c′)− pi(c, c) ≥ F .
In this paper, we refer to cooperative R&D under patent protection as cooperation in
stage 1 for R&D investment, but product competition between two firms in stage 2. For
simplicity, we assume that if two firms choose cooperative R&D in stage 1, they share the
cost F equally, reducing each firm’s marginal cost from c to c′. In this case, each firm’s
payoff is pi(c′, c′)− F
2
.
In general, R&D activities are time-consuming and need to last for a long period, such
as with pharmaceutical innovations.1 We accordingly assume that if one firm chooses to
cooperate in R&D, but the other firm chooses to innovate by itself, it is likely that the firm
choosing to cooperate in R&D realizes its rival’s decision, and adds another half cost to incur
the entire cost F in order to accomplish the innovation. So in this case, both firms are still
engaged in the patent tournament and each firm’s expected payoff is pi1(c
′,c)+pi1(c,c′)
2
− F .
Solving the game by backward induction, Table 1 illustrates the firms’ payoffs in stage 1
under patent protection in the presence of a cooperative R&D option.
Table 1: Payoffs under patent protection with a cooperative R&D option
Cooperative R&D No R&D
Cooperative R&D pi(c′, c′)− F
2
, pi(c′, c′)− F
2
pi1(c
′, c)− F , pi2(c′, c)
No R&D pi1(c, c
′), pi2(c, c′)− F pi(c, c), pi(c, c)
Following the definitions of the non-strategic and strategic incentives for R&D investment
in Roy Chowdhury (2005), where the non-strategic (strategic) incentive is firm i’s payoff from
R&D, minus its payoff from not doing R&D when firm j does not invest (invests) in R&D,
the non-strategic incentive N(C) and the strategic incentive S(C) of firm 1 under cooperative
1Prentis, Lis, and Walker (1988) show that, regarding British pharmaceutical innovations, the “average
development times increased from less than 2 years between 1964 and 1965, to around 8 years in the 1980s
with a consequent reduction in the effective patent life”.
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R&D are respectively given by:
N(C) = pi1(c
′, c)− pi(c, c)− F (1)
and
S(C) = pi(c′, c′)− pi1(c, c′)− F
2
. (2)
Given pi1(c
′, c) > pi(c′, c′), pi1(c, c′) < pi(c, c) and Assumption 1, we have that N(C) > 0
and S(C) > 0, which implies that both firms cooperatively investing in R&D constitutes an
equilibrium.
3 Cooperative R&D and Patent Protection
In this section, we investigate the firms’ choice of R&D investment under patent protec-
tion with a cooperative R&D option. In Roy Chowdhury (2005), the non-strategic incentive
N(P ) and strategic incentive S(P ) for R&D under only patent protection (or patent com-
petition) are N(P ) = pi1(c
′, c)− pi(c, c)− F and S(P ) = pi1(c′,c)+pi1(c,c′)
2
− pi1(c, c′)− F .
Obviously, the non-strategic incentive for R&D does not change regardless of whether or
not a cooperative R&D option is available under patent protection. Next, we only need to
compare the strategic incentive for R&D investment between patent protection and cooper-
ative R&D, which is given by:
S(P )− S(C) =
[
pi1(c
′, c) + pi1(c, c′)
2
− pi(c′, c′)
]
− F
2
. (3)
The first term in the square bracket is the tournament effect (TE). Consequently, (3) indicates
that two firms should choose the patent tournament if and only if S(P )− S(C) ≥ 0, or TE
≥ F/2; otherwise, the cooperative R&D option is preferred under patent protection. Thus,
we have the following proposition:
Proposition 1. The firms’ R&D incentive always increases under patent protection with a
cooperative R&D option, irrespective of the tournament effect.
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When there is only patent protection, both firms invest in R&D if S(P ) > 0. However,
after giving the presence of R&D cooperation under patent protection, both firms always
conduct R&D in the subgame perfect Nash equilibria of the 2-stage game. In summary:
Proposition 2. (I) If S(P ) ≥ S(C) > 0, there exists an equilibrium where both firms invest
in R&D with patent competition; (II) If S(C) > S(P ) > 0 or S(C) > 0 ≥ S(P ), there exists
an equilibrium where both firms undertake cooperative R&D.
Further, welfare may be also improved in the equilibrium where both firms undertake
cooperative R&D, as the duplication of R&D investment would be avoided, while both firms
benefit from the new technology.
4 Cooperative R&D versus Imitation and Royalty Li-
censing
Mukherjee (2006) introduces non-infringing imitation and royalty licensing under patent
protection, and shows that their effects may always dominate the tournament effect and thus
raise the firms’ R&D incentive. In this section, we compare the effects of the cooperative
R&D option, imitation, and royalty licensing on the R&D incentive under patent protection.
4.1 Cooperative R&D versus Imitation
Under patent protection with non-infringing imitation, two firms still compete to obtain
the patent, with a probability of 1/2, by doing bilateral R&D. Additionally, the non-patent
holder can invest I > 0 around the protected technology with a successful probability of
z ∈ (0, 1), and then obtains a similar technology to reduce its marginal cost from c to
c′. For unilateral R&D, imitation reduces the marginal cost of the non-innovating firm
from c to c˜. Under this regime, the non-strategic and strategic incentives for the R&D
of a firm (e.g. firm 1) are N(I) = zpi1(c
′, c˜) + (1 − z)pi1(c′, c) − pi(c, c) − F and S(I) =
z[pi(c′, c′)− pi1(c˜, c′)] + (1−z)2 [pi(c′, c)− pi1(c, c′)]− F + I2 , respectively.
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We first compare the non-strategic incentive between cooperative R&D and imitation:
N(C)−N(I) = z[pi1(c′, c)− pi1(c′, c˜)]. (4)
Obviously, (4) > 0; cooperative R&D creates a higher non-strategic incentive for R&D
investment than imitation. Further, the comparison of strategic incentive gives:
S(C)− S(I) = (1− z)
[
pi(c′, c′)− pi1(c
′, c) + pi1(c, c′)
2
]
+ z[pi1(c˜, c
′)− pi1(c, c′)] + F − I
2
. (5)
Mukherjee (2006) claims that successful imitation is very likely, i.e. z → 1. This is because,
after the patent tournament where both firms invested in R&D, the non-patent holder has
already incurred F in innovation research. Hence, it possesses a sufficient amount of knowl-
edge about the new technology, leading the non-infringing imitation to be easily achieved.
Given that z → 1 and F > I, (5) > 0. That is, cooperative R&D induces a higher strategic
incentive for R&D investment than imitation. To summarize, the cooperative R&D option
strictly dominates imitation for increasing the R&D incentive under patent protection.
4.2 Cooperative R&D versus Royalty Licensing
Under patent protection with royalty licensing, the firms remain competing in a patent
tournament with a probability of 1/2. The patent holder (licenser) may sell a license to the
non-patent holder (licensee) by charging a royalty of G(., .), so that the licensee can also
reduce its marginal cost from c to c′. In this case, the non-strategic and strategic incentives
for the R&D of the patent holder (e.g. firm 1) are N(RL) = pi1(c
′, c) +G(c′, c)− pi(c, c)−F
and S(RL) = pi1(c
′,c)+G(c′,c)−pi1(c,c′)
2
− F , respectively.
It is easy to see that royalty licensing creates a higher non-strategic incentive for R&D
investment than cooperative R&D, since N(RL) − N(C) > 0. However, the comparison of
the strategic incentive becomes ambiguous:
S(C)− S(RL) = pi(c′, c′)− pi1(c
′, c) + pi1(c, c′)
2
− G(c
′, c)
2
+
F
2
, (6)
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where we could have (6) S 0, depending on the magnitude of F .2 Thereby, it is possible
that either regime induces a higher incentive for R&D investment under patent protection.
Summarizing Section 4 shows:
Proposition 3. Under patent protection, (I) a cooperative R&D option generates a higher
incentive for R&D investment than imitation; (II) either cooperative R&D or royalty licens-
ing would be preferred to increase the R&D incentive, particularly depending on the R&D
cost.3
5 Conclusion
This paper shows that patent protection in the presence of a cooperative R&D option
always increases the R&D incentive, irrespective of the tournament effect. Further, under
patent protection, the cooperative R&D option always generates a higher incentive for R&D
investment compared to imitation. However, the dominance of this option becomes unclear
when compared with royalty licensing.
Appendix
Proofs for Patent Protection with Licensing
This note illustrates that fixed-fee licensing under patent protection will always create
higher R&D incentives than under no patent protection, irrespective of the tournament effect
2In Mukherjee (2006), the optimal level of royalty implies pi1(c
′, c) +G(c′, c) > 2pi(c′, c′)− pi1(c, c′).
3Che and Yang (2009) consider the case of patent protection with fixed-fee licensing. They show that, in
the presence of fixed-fee licensing, both non-strategic and strategic R&D incentives are higher under patent
protection than under no patent protection. Here, we further compare the R&D incentive of cooperative
R&D and fixed-fee licensing under patent protection. Following Che and Yang (2009), the non-strategic
and strategic incentives for the R&D of a firm (e.g. firm 1) with fixed-fee licensing are N(FL) = pi(c′, c′)−
pi(c, c) +K(c′, c)−F and S(FL) = K(c′, c)−F , where the licenser can offer a licensing contract with a fixed
fee K(., .), and the licensee accepts the contract if it is not worse off than being without fixed-fee licensing.
Since the game is symmetric, the optimal license is given by K(c′, c) = pi(c′, c′)−pi1(c, c′) = pi1(c′, c)−pi(c′, c′).
The comparison of non-strategic and strategic incentives between the regimes shows that N(C)−N(FL) =
pi1(c
′, c)− pi(c′, c′)−K(c′, c) = 0 and S(C)−S(FL) = F/2 > 0, suggesting that cooperative R&D generates
a higher incentive for R&D investment than fixed-fee licensing under patent protection.
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(TE). According to Wang (1998), fixed-fee licensing for the patent-holding firm is inferior
to royalty licensing when the cost-reducing innovation is non-drastic. This result is also
implicitly given by Rockett (1990), who considers both fixed-fee and royalty licensing and
concludes that in equilibrium, the fixed-fee is zero and only the output royalty is positive.
Mukherjee (2006) has already proven that royalty licensing under patent protection may
always induce higher incentives for R&D investment than under no patent protection, irre-
spective of TE, which is introduced by Roy Chowdhury (2005). In the following, we show
that fixed-fee licensing also has a similar role.
First of all, the natural restrictions and symmetry on the duopoly profits specified in
Roy Chowdhury (2005) still apply. Fixed-fee licensing has a net profit transferred from the
licensee (firm 2) to the licenser (firm 1). The optimal level of fixed fees charged by firm
1 should be the amount that makes firm 2 indifferent between licensing and no licensing.
Given that the game is symmetric, we should have
G(c′, c) = pi1(c′, c)− pi(c′, c′) = pi(c′, c′)− pi2(c′, c). (7)
In fact, this equation implies that TE equals zero. If both firms invest in R&D, the net profit
transferred from the licensee to the licenser when the license is sold yields firm 1’s payoff, as
follows:
1
2
[(p(c′, c′)− c′)q1(c′, c′) +G(c′, c)] + 1
2
[(p(c′, c′)− c′)q1(c′, c′)−G(c′, c)]− F
=
1
2
pi(c′, c′) +
1
2
pi(c′, c′)− F = pi(c′, c′)− F.
(8)
where p(c′, c′) and q1(c′, c′) represent the market price and the quantity produced by firm 1
when the license is sold, respectively. The fixed-fee G(c′, c˜) under no patent protection with
licensing is calculated using the same logic as (A.1), implying G(c′, c˜) = pi(c′, c′)−pi2(c′, c˜) =
pi1(c
′, c˜)−pi(c′, c′). Consequently, using G(c′, c) and G(c′, c˜), the game matrices can be written
as follows.
In both tables, the strategies of firm 1 and firm 2 are labeled vertically and horizontally.
8
Table 2: Payoffs under no patent protection with fixed-fee licensing
R&D No R&D
R&D pi(c′, c′)− F , pi(c′, c′)− F pi(c′, c′) +G(c′, c˜)− F , pi2(c′, c˜)
No R&D pi1(c˜, c
′), pi(c′, c′) +G(c˜, c′)− F pi(c, c), pi(c, c)
Table 3: Payoffs under patent protection with fixed-fee licensing
R&D No R&D
R&D pi(c′, c′)− F , pi(c′, c′)− F pi(c′, c′) +G(c′, c)− F ,
pi(c′, c′)−G(c′, c)
No R&D pi(c′, c′)−G(c, c′), pi(c′, c′) +G(c, c′)− F pi(c, c), pi(c, c)
For every payoff vector, the first and second expressions represent the net equilibrium payoff
of firm 1 and firm 2, respectively.
Thus, from Table 2, we know that the non-strategic and strategic incentives for R&D
under no patent protection with fixed-fee licensing for each firm are N(NPL) = pi(c′, c′) −
pi(c, c) +G(c′, c˜)−F and S(NPL) = pi(c′, c′)−pi(c˜, c′)−F . Similarly, Table 3 gives the non-
strategic and strategic incentives for R&D under patent protection with fixed-fee licensing
for each firm as N(FL) = pi(c′, c′) − pi(c, c) + G(c′, c) − F and S(FL) = G(c′, c) − F . The
direct comparison between S(FL) and S(NPL) using the optimal licensing fixed fee yields
S(FL)− S(NPL) = pi1(c˜, c′)− pi1(c, c′) > 0. (9)
Similarly, the comparison between N(FL) and N(NPL) yields
N(FL)−N(NPL) = G(c′, c)−G(c′, c˜) = pi1(c˜, c′)− pi1(c, c′) > 0. (10)
This result implies that fixed-fee licensing under patent protection also generates higher
incentives for R&D investment than under no patent protection, irrespective of TE. This is
because TE becomes zero under this regime, and patent protection eliminates the technology
spillover from the innovating firm to the non-innovating firm.
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